Human Nonalcoholic Steatohepatitis on a Chip
Nonalcoholic steatohepatitis (NASH), an advanced stage of nonalcoholic fatty liver disease (NAFLD), is a rapidly growing and global health problem compounded by the current absence of specific treatments. A major limiting factor in the development of new NASH therapies is the absence of models that...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2021-02-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1647 |